The United States Food and Drug Administration (FDA) has suspended the licence of one of the two chikungunya vaccines ...

Delhi's record-breaking rainfall this month has been accompanied by a surge in dengue cases, with 121 reported so far. Experts predict a further rise due to the heavy rainfall.

The U.S. FDA has suspended the license for Valneva’s chikungunya vaccine Ixchiq after reports of severe side effects, ...

The cities of Foshan and Guangzhou, in southern China, have been battling the virus for two months. Nearly 10,000 cases have ...

Experts fear cases may rise during the next two weeks; city also reported 56 malaria and 12 chikungunya cases this month ...

By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...

US health authorities have suspended the licence for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events”, the drug’s French maker said Monday.

The decision to suspend the Ixchiq vaccine comes as public health experts warn the mosquito-spread virus could pose a future pandemic threat.

The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker ...

Analysts on Monday expressed divergent opinions on vaccine company Valneva SE (VALN) after the firm said that the United ...

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.